Abstract

We compared ages of patients with advanced melanoma, breast, lung, liver, or kidney cancer in recently completed real-world evidence (RWE) chart review studies, multinational randomized clinical trials (RCTs) upon which the RWE studies were based, and the most recently available Surveillance, Epidemiology, and End Results (SEER) data.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.